1. Home
  2. AMPS vs PRTA Comparison

AMPS vs PRTA Comparison

Compare AMPS & PRTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMPS
  • PRTA
  • Stock Information
  • Founded
  • AMPS 2009
  • PRTA 2012
  • Country
  • AMPS United States
  • PRTA Ireland
  • Employees
  • AMPS N/A
  • PRTA N/A
  • Industry
  • AMPS Electric Utilities: Central
  • PRTA Biotechnology: Pharmaceutical Preparations
  • Sector
  • AMPS Utilities
  • PRTA Health Care
  • Exchange
  • AMPS Nasdaq
  • PRTA Nasdaq
  • Market Cap
  • AMPS 790.9M
  • PRTA 809.8M
  • IPO Year
  • AMPS N/A
  • PRTA N/A
  • Fundamental
  • Price
  • AMPS $4.95
  • PRTA $12.14
  • Analyst Decision
  • AMPS Buy
  • PRTA Buy
  • Analyst Count
  • AMPS 9
  • PRTA 9
  • Target Price
  • AMPS $5.13
  • PRTA $54.57
  • AVG Volume (30 Days)
  • AMPS 2.0M
  • PRTA 454.8K
  • Earning Date
  • AMPS 03-17-2025
  • PRTA 05-07-2025
  • Dividend Yield
  • AMPS N/A
  • PRTA N/A
  • EPS Growth
  • AMPS N/A
  • PRTA N/A
  • EPS
  • AMPS 0.01
  • PRTA N/A
  • Revenue
  • AMPS $196,265,000.00
  • PRTA $135,157,000.00
  • Revenue This Year
  • AMPS $19.96
  • PRTA N/A
  • Revenue Next Year
  • AMPS $18.81
  • PRTA $131.75
  • P/E Ratio
  • AMPS $601.48
  • PRTA N/A
  • Revenue Growth
  • AMPS 26.49
  • PRTA 47.92
  • 52 Week Low
  • AMPS $2.71
  • PRTA $11.42
  • 52 Week High
  • AMPS $5.50
  • PRTA $25.42
  • Technical
  • Relative Strength Index (RSI)
  • AMPS 61.44
  • PRTA 38.46
  • Support Level
  • AMPS $4.93
  • PRTA $11.42
  • Resistance Level
  • AMPS $4.97
  • PRTA $13.52
  • Average True Range (ATR)
  • AMPS 0.02
  • PRTA 0.75
  • MACD
  • AMPS -0.02
  • PRTA -0.12
  • Stochastic Oscillator
  • AMPS 37.50
  • PRTA 24.66

About AMPS Altus Power Inc.

Altus Power Inc is a developer, owner, and operator of large-scale photovoltaic and energy storage systems across the United States. The company serves commercial, industrial, public sector, and community solar customers. Its mission is to drive the clean energy transition by developing and operating solar generation and energy storage facilities. It owns a diverse portfolio of solar PV systems and has long-term agreements with enterprise entities and residential customers. Its primary product offerings include leases and revenue contracts for solar power generation, alongside electric vehicle charging and energy storage solutions. Revenue streams include power purchase agreements, net metering credit agreements, and SREC revenue.

About PRTA Prothena Corporation plc

Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Share on Social Networks: